肾肿瘤前哨淋巴结SPECT/CT显像未显示因素分析
73例可评估患者中,46例检出前哨淋巴结,术前可视化率63%,术中检出率61%,多因素分析显示仅年龄与未显示相关,年龄越高未显示风险越高。
要点
- 肾肿瘤前哨淋巴结SPECT/CT术前可视化率为63%,术中检出率为61%。
- 多因素分析显示年龄是前哨淋巴结未显示的独立相关因素。
- 肾脏及肿瘤高血供可能导致示踪剂洗脱,但该效应在本数据中无统计学结论。
核心结论
- 肾肿瘤前哨淋巴结SPECT/CT显像未显示率较高,且与患者年龄相关,年龄越高未显示风险越高。
主要发现
- 46例患者共检出80枚前哨淋巴结(均值1.1,IQR 0-2,最大6)。
- 术前可视化率为63%[95%CI 50-73%],术中检出率为61%[95%CI 49-72%]。
- 单因素和多因素分析中,唯一与未显示相关的因素为年龄,年龄越高未显示风险越高。
- 肾脏及肿瘤高血供可能导致洗脱效应,但本数据中该效应无统计学结论。
临床怎么用
- 肾肿瘤前哨淋巴结活检术前应告知患者SPECT/CT显像未显示率较高,年龄较高者未显示风险更高。
- 该未显示率限制了前哨淋巴结活检在肾癌研究和临床中的应用,需进一步研究改善显像并标准化操作流程。
局限性
- 肾脏及肿瘤高血供所致洗脱效应在本数据中无统计学结论。
- 前哨淋巴结未显示率较高,限制该技术的研究和临床应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sentinel lymph node biopsy (SLNB) after intratumoral injection of 99mTc labeled nanocolloid and imaging with scintigraphy and SPECT/CT in renal tumors is feasible. However, sentinel lymph node (SN) non-detection rate with scintigraphy and SPECT/CT is high. The aim of the study was to determine factors affecting non-visualization (NV) of SN imaging in renal tumors. Seventy-eight patients with cT1-3 renal tumors received intratumoral injection of 225 MBq 99mTc-labeled nanocolloid 1 day before (partial) nephrectomy. Radiotracer injection was followed by anterioposterior and lateral scintigraphy in combination with SPECT/CT 20 min and 2-4 h after. Surgical treatment of the tumor with sentinel lymph node biopsy by aid of γ-probe and-camera was performed the next day. Scintigraphy and SPECT/CT images were evaluated and patient, tumor, and procedure characteristics were collected for 73 eligible patients used in uni- and multivariable analysis of a potential association with NV. RESULTS: A total of 80 (mean 1.1, IQR 0-2, max 6) sentinel lymph nodes in 46 patients were detected with scintigraphy and SPECT/CT. Preoperative visualization rate and intraoperative detection rate was 63% [95% CI 50-73%] and 61% [95% CI 49-72%], respectively. In uni- and multivariable analysis, the only factor associated with non-visualization was age, showing higher odds of non-visualization with higher age. CONCLUSION: Our study demonstrated that non-visualization of SNs in renal tumors is relatively high and is associated with patient age. Furthermore, kidneys and also its tumors are highly vascularized which may cause a wash-out effect that could be identified with decreased kidney-liver ratios. However, in our data, the effect was statistically inconclusive. Further studies are needed to improve visualization and standardize the procedure of SLNB in renal tumors. The percentage of NV limits the use of SLNB for research and clinical purposes in renal cancer.
引用
- Kuusk T, Donswijk ML, Valdés Olmos RA, et al. An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors. EJNMMI Res. 2018. PMID: 30511175. doi:10.1186/s13550-018-0460-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。